Browsing by Author Morey, Adrienne

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 17 of 17
Issue DateTitleAuthor(s)Citation
2005Assessment of HER-2 status in pancreatic adenocarcinoma: correlation of immunohistochemistry, quantitative real-time RT-PCR, and FISH with aneuploidy and survival.Nielsen, AiQun; Saxby, Alex; Scarlett, C; Smith, Ross; Clarkson, Adele; Gill, Anthony; Morey, Adrienne; Northern Clinical School: Medicine; Clinical Schools; Northern Clinical School: Medicine; Northern Clinical School: SurgeryAssessment of HER-2 status in pancreatic adenocarcinoma: correlation of immunohistochemistry, quantitative real-time RT-PCR, and FISH with aneuploidy and survival., American Journal of Surgical Pathology, vol.29, 9, 2005,pp 1125-1134
2009BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breastMcNeil, Catriona; O'Toole, Sandra; Anderson, Luke R.; Biankin, Andrew V.; Butt, Alison Joy; Crea, P; Henshall, Susan M.; Millar, E.; Morey, Adrienne; Musgrove, Elizabeth A.; Pinese, Mark; Sutherland, Robert L.; Western Clinical School: Medicine (Westmead); Central Clinical School: PathologyBAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast, British Journal of Cancer, vol.100, 1,pp 123-133
2014c-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancerArmstrong, Nicola Joy; Naylor, Matthew; O'Toole, Sandra; Baker, Laura; Cowley, Mark; Herschkowitz, Jason I; Hui, Mun; Junankar, Simon; Kaplan, Warren; Lakhani, Sunil R.; McFarland, Andrea; Morey, Adrienne; Nair, Radhika; Nguyen, Akira; Nicolic, I; Ormandy, Christopher J.; Perou, Charles M; Pfefferle, Adam; Roden, Daniel; Selinger, Christina; Shah, Jaynish; Swarbrick, A.; Teo, W S; Usary, Jerry E; Yang, J; Ye, S; Mathematics & Statistics; School of Medical Sciences: Physiology; Central Clinical School: Pathologyc-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancer, Oncogene, vol.33, 30, 2014,pp 3992-4002
2013Clinical and molecular characterization of HER2 amplified-pancreatic cancerGill, Anthony; Toon, Christopher; Biankin, Andrew V.; Chang, David K.; Chantrill, Lorraine; Chin, Venessa; Chou, Angela; Cowley, Mark; Goldstein, David; Grimmond, Sean Michael; Humphris, Jeremy; Johns, Amber; Kassahn, Karin; Mead, Scott; Miller, David K; Morey, Adrienne; Musgrove, Elizabeth A.; Nagrial, Adnan; Nones, Katia; Pajic, Marina; Patch, Anne-Marie; Pearson, John V; Pinese, Mark; Rooman, Ilse; Samra, JS; Waddell, Nic; Wasan, Harpreet; Wu, Jianmin; Deans Unit: (CIPHER); Northern Clinical School: Kolling InstituteClinical and molecular characterization of HER2 amplified-pancreatic cancer, Genome Medicine, vol.5, 8, 2013,pp 1-11
2009Diagnosis of cutaneous melanocytic tumours by four-colour fluorescence in situ hybridisationMann, Graham; McCarthy, Stanley; Murali, Rajmohan; Scolyer, Richard; Morey, Adrienne; Western Clinical School: Westmead Millennium Institute; Central Clinical School: Inst. of Anatomical Pathology RPAH; Central Clinical School: Pathology; Central Clinical School: PathologyDiagnosis of cutaneous melanocytic tumours by four-colour fluorescence in situ hybridisation, Pathology, vol.41,(4),2009,pp 383-387
2002DPC4/Smad4 Expression and Outcome in Pancreatic Ductal AdenocarcinomaLee, Cheok; Biankin, Andrew V.; Biankin, S. A.; Head, D. R.; Henshall, Susan M.; Hook, Henry C.; Hugh, Thomas B.; Kench, James; Morey, Adrienne; Sutherland, Robert L.; Central Clinical School: MedicineDPC4/Smad4 Expression and Outcome in Pancreatic Ductal Adenocarcinoma, Journal of Clinical Oncology, vol.20,(23),2002,pp 4531-4542
2015Equivocal ALK fluorescence in-situ hybridization (FISH) cases may benefit from ancillary ALK FISH probe testingCooper, Wendy Anne; Gill, Anthony; Pavlakis, Nick; Amanuel, Benhur; Christie, Michael; Diakos, Connie; Lum, Trina; McNeil, Catriona; Millward, Michael; Morey, Adrienne; O'Toole, Sandra; Peverall, Joanne; Selinger, Christina; Tran, Yen; Van Vliet, Chris; Waring, Paul; Central Clinical School: Medicine; Northern Clinical School: Pathology; Northern Clinical School: MedicineEquivocal ALK fluorescence in-situ hybridization (FISH) cases may benefit from ancillary ALK FISH probe testing, Histopathology, vol.67, 5, 2015,pp 654-663
2010Establishment of the Australian In Situ Hybridization Program for the Assessment of HER2 Amplification in Breast Cancer: A Model for the Introduction of New Biomarkers Into Clinical PracticeBilous, Michael; Armes, Jane; Bell, Richard (Prof); Cummings, Margaret; Farshid, G; Fox, Stephen B.; Francis, Glenn; Haswell, Martin; McCue, Glenda; Morey, Adrienne; Raymond, W.; Robbins, Peter; Western Clinical School: Medicine (Westmead)Establishment of the Australian In Situ Hybridization Program for the Assessment of HER2 Amplification in Breast Cancer: A Model for the Introduction of New Biomarkers Into Clinical Practice, Diagnostic Molecular Pathology, vol.19, 4,pp 187-193
2009Expression of S100A2 Calcium-Binding Protein Predicts Response to Pancreatectomy for Pancreatic CancerKench, James; Lee, Cheok; Biankin, Andrew; Chang, David K.; Colvin, E K; Cosman, P H; et al, Various; Kuo, Samuel; Morey, Adrienne; Nguyen, Nam; Pinese, Mark; Scarlett, Christopher; Segara, Davendra; Susanto, J; School of Medical Sciences: Pathology; Central Clinical School: MedicineExpression of S100A2 Calcium-Binding Protein Predicts Response to Pancreatectomy for Pancreatic Cancer, Gastroenterology, vol.137, 2, 2009,pp 558-568
2016HER2 expression in oesophageal carcinoma and Barrett's oesophagus associated adenocarcinoma: An Australian studyCox, Michael; Eslick, Guy; Nagaraja, V; Morey, Adrienne; Shaw, N; Nepean Clinical School: Medicine; Nepean Clinical School: Surgery; SurgeryHER2 expression in oesophageal carcinoma and Barrett's oesophagus associated adenocarcinoma: An Australian study, European Journal of Surgical Oncology, vol.42, 1, 2016,pp 140-148
2010High Notch1 protein expression is an early event in breast cancer development and is associated with the HER-2 molecular subtypeHamilton, Anne; Lee, Cheok; McNeil, Catriona; Spillane, Andrew; Crea, P; Lopez-Knowles, Elena; McLeod, Duncan; Millar, Ewan; Morey, Adrienne; Murphy, N C; Musgrove, Elizabeth A.; Oakes, Samantha; Ormandy, Christopher J.; O'Toole, Sandra; Pinese, Mark; Qiu, Min; Sutherland, Robert L.; Zardawi, Ibrahim; Zardawi, Sarah J; Central Clinical School: Medicine; Central Clinical School: Medicine; Western Clinical School: Medicine (Westmead); Northern Clinical School: MedicineHigh Notch1 protein expression is an early event in breast cancer development and is associated with the HER-2 molecular subtype, Histopathology, vol.56, 3,pp 286-296
2014National Working Group Meeting on ALK diagnostics in lung cancerCooper, Wendy Anne; O'Toole, Sandra; Dettrick, Andrew; et al, Various; Fox, Stephen; Frances, Glenn; Leong, Trishe; Morey, Adrienne; OBrien, Kenneth; Pavlakis, Nick; Rathi, Vivek; Spagnolo, Dominic; Central Clinical School: Medicine; Central Clinical School: PathologyNational Working Group Meeting on ALK diagnostics in lung cancer, Asia-Pacific Journal of Clinical Oncology, vol.10, S 2, 2014,pp 11-17
2004Pancreatic Intraepithelial Neoplasia In Association With Intraductal Papillary Mucinous Neoplasms Of The Pancreas: Implications For Disease Progression And Recurrence.Soon, Lee; Biankin, Andrew V.; Biankin, Sandra A.; Coleman, Maxwell J.; Dijkman, Floriaan P.; Henshall, Susan M.; Kench, James; Morey, Adrienne; Sutherland, Robert L.; School of Medical Sciences: PathologyPancreatic Intraepithelial Neoplasia In Association With Intraductal Papillary Mucinous Neoplasms Of The Pancreas: Implications For Disease Progression And Recurrence., American Journal of Surgical Pathology, vol.28,(9),2004,pp 1184-1192
2015Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) TrialChin, Venessa; Gill, Anthony; Grimison, Peter; Nagrial, Adnan; Pavlakis, Nick; Samra, Jaswinder; Sebastian, Lucille; Simes, Robert John; Sjoquist, Katrin; Yip, Sonia; Asghari, R; Biankin, Andrew; Brown, Belinda; Chang, David; Chantrill, Lorraine; Chou, Angela; Grimmond, Sean; Harvey, Sandra L; Humphris, Jeremy; Johns, Amber L; Jones, Mark D; Martyn-Smith, Mona; Mead, Scott; Morey, Adrienne; Pajic, Marina; Simpson, Skye H; Thomas, David; Watson, Clare; Watson, Nicole; Central Clinical School: Medicine; Northern Clinical School: Pathology; NH&MRC Clinical Trials Centre; Medicine; Northern Clinical School: Medicine; Northern Clinical School: Surgery; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentrePrecision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial, Clinical Cancer Research, vol.21, 9, 2015,pp 2029-2037
2003Predicting the HER2 status of breast cancer from basic histopathology data: an analysis of 1500 breast cancers as part of the HER2000 international studyBilous, Michael; Ades, C.; Armes, Jane E.; Bishop, J.; Brown, Richard P C; Cooke, B; Cummings, M; Farshid, Gelareh; Field, A; McKenzie, Paul R; Morey, Adrienne; Raymond, W.; Robbins, P.; Tan, L.; Western Clinical School: Medicine (Westmead)Predicting the HER2 status of breast cancer from basic histopathology data: an analysis of 1500 breast cancers as part of the HER2000 international study, The Breast, vol.12,(2),2003,pp 92-98
2014Reflex ALK immunohistochemistry is feasible and highly specific for ALK gene rearrangements in lung cancerCooper, Wendy Anne; Gill, Anthony; Houang, Michelle; O'Toole, Sandra; Toon, Christopher Chien; Chou, Angela; Clarkson, Adele; Farzin, Mahtab; Morey, Adrienne; Selinger, Christina; Sioson, Loretta; Watson, Nicole; Central Clinical School: Medicine; Northern Clinical School: Pathology; Northern Clinical School: Medicine; Central Clinical School: Pathology; Northern Clinical School: Kolling InstituteReflex ALK immunohistochemistry is feasible and highly specific for ALK gene rearrangements in lung cancer, Pathology, vol.46, 5, 2014,pp 383-388
2010Silver In Situ Hybridization (SISH) For Determination of HER2 Gene Status in Breast Carcinoma: Comparison With FISH and Assessment of Interobserver ReproducibilityBilous, Michael; Downs-Kelly, Erinn; et al, various; Lloyd, Ricardo; Morey, Adrienne; Myles, Jonathon; Nagle, Ray; Oliveira, Andre; Papouchado, Bettina; Prescott, Nichole; Stoler, Mark; Western Clinical School: Medicine (Westmead)Silver In Situ Hybridization (SISH) For Determination of HER2 Gene Status in Breast Carcinoma: Comparison With FISH and Assessment of Interobserver Reproducibility, American Journal of Surgical Pathology, vol.34, 6,pp 767-776